世界の網膜用生物製剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Retinal Biologics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4821 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、網膜用生物製剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（黄斑変性症、糖尿病性網膜症、糖尿病性黄斑浮腫、ブドウ膜炎、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・網膜用生物製剤の市場動向 ・企業の競争状況、市場シェア ・網膜用生物製剤の種類別市場規模と予測2016-2027（黄斑変性症、糖尿病性網膜症、糖尿病性黄斑浮腫、ブドウ膜炎、その他） ・網膜用生物製剤の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・網膜用生物製剤の北米市場規模2016-2027（アメリカ、カナダ） ・網膜用生物製剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・網膜用生物製剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・網膜用生物製剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・網膜用生物製剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Spark Therapeutics, Inc、F. Hoffmann-La Roche Ltd、Regeneron Pharmaceuticals, Inc、AbbVie Inc、Johnson & Johnson Services, Inc、Amgen Inc） ・結論

Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug Administration (CFDA) for the treatment of retinal diseases. Advancements in technologies and new mechanism of action for different biologics to treat retinal diseases are anticipated to boost the retinal biologics market.

Market Analysis and Insights: Global Retinal Biologics Market
The global Retinal Biologics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retinal Biologics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retinal Biologics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retinal Biologics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retinal Biologics market.

Global Retinal Biologics Scope and Market Size
Retinal Biologics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retinal Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Macular Degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Uveitis
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Spark Therapeutics, Inc
F. Hoffmann-La Roche Ltd
Regeneron Pharmaceuticals, Inc
AbbVie Inc
Johnson & Johnson Services, Inc
Amgen Inc

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Biologics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Macular Degeneration
1.2.3 Diabetic Retinopathy
1.2.4 Diabetic Macular Edema
1.2.5 Uveitis
1.2.6 Others
1.3 Market by Application
1.3.1 Global Retinal Biologics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Retinal Biologics Market Perspective (2016-2027)
2.2 Retinal Biologics Growth Trends by Regions
2.2.1 Retinal Biologics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retinal Biologics Historic Market Share by Regions (2016-2021)
2.2.3 Retinal Biologics Forecasted Market Size by Regions (2022-2027)
2.3 Retinal Biologics Industry Dynamic
2.3.1 Retinal Biologics Market Trends
2.3.2 Retinal Biologics Market Drivers
2.3.3 Retinal Biologics Market Challenges
2.3.4 Retinal Biologics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Retinal Biologics Players by Revenue
3.1.1 Global Top Retinal Biologics Players by Revenue (2016-2021)
3.1.2 Global Retinal Biologics Revenue Market Share by Players (2016-2021)
3.2 Global Retinal Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retinal Biologics Revenue
3.4 Global Retinal Biologics Market Concentration Ratio
3.4.1 Global Retinal Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Biologics Revenue in 2020
3.5 Retinal Biologics Key Players Head office and Area Served
3.6 Key Players Retinal Biologics Product Solution and Service
3.7 Date of Enter into Retinal Biologics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Retinal Biologics Breakdown Data by Type
4.1 Global Retinal Biologics Historic Market Size by Type (2016-2021)
4.2 Global Retinal Biologics Forecasted Market Size by Type (2022-2027)

5 Retinal Biologics Breakdown Data by Application
5.1 Global Retinal Biologics Historic Market Size by Application (2016-2021)
5.2 Global Retinal Biologics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Retinal Biologics Market Size (2016-2027)
6.2 North America Retinal Biologics Market Size by Type
6.2.1 North America Retinal Biologics Market Size by Type (2016-2021)
6.2.2 North America Retinal Biologics Market Size by Type (2022-2027)
6.2.3 North America Retinal Biologics Market Size by Type (2016-2027)
6.3 North America Retinal Biologics Market Size by Application
6.3.1 North America Retinal Biologics Market Size by Application (2016-2021)
6.3.2 North America Retinal Biologics Market Size by Application (2022-2027)
6.3.3 North America Retinal Biologics Market Size by Application (2016-2027)
6.4 North America Retinal Biologics Market Size by Country
6.4.1 North America Retinal Biologics Market Size by Country (2016-2021)
6.4.2 North America Retinal Biologics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Retinal Biologics Market Size (2016-2027)
7.2 Europe Retinal Biologics Market Size by Type
7.2.1 Europe Retinal Biologics Market Size by Type (2016-2021)
7.2.2 Europe Retinal Biologics Market Size by Type (2022-2027)
7.2.3 Europe Retinal Biologics Market Size by Type (2016-2027)
7.3 Europe Retinal Biologics Market Size by Application
7.3.1 Europe Retinal Biologics Market Size by Application (2016-2021)
7.3.2 Europe Retinal Biologics Market Size by Application (2022-2027)
7.3.3 Europe Retinal Biologics Market Size by Application (2016-2027)
7.4 Europe Retinal Biologics Market Size by Country
7.4.1 Europe Retinal Biologics Market Size by Country (2016-2021)
7.4.2 Europe Retinal Biologics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Retinal Biologics Market Size (2016-2027)
8.2 Asia-Pacific Retinal Biologics Market Size by Type
8.2.1 Asia-Pacific Retinal Biologics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retinal Biologics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retinal Biologics Market Size by Type (2016-2027)
8.3 Asia-Pacific Retinal Biologics Market Size by Application
8.3.1 Asia-Pacific Retinal Biologics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retinal Biologics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retinal Biologics Market Size by Application (2016-2027)
8.4 Asia-Pacific Retinal Biologics Market Size by Region
8.4.1 Asia-Pacific Retinal Biologics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retinal Biologics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Retinal Biologics Market Size (2016-2027)
9.2 Latin America Retinal Biologics Market Size by Type
9.2.1 Latin America Retinal Biologics Market Size by Type (2016-2021)
9.2.2 Latin America Retinal Biologics Market Size by Type (2022-2027)
9.2.3 Latin America Retinal Biologics Market Size by Type (2016-2027)
9.3 Latin America Retinal Biologics Market Size by Application
9.3.1 Latin America Retinal Biologics Market Size by Application (2016-2021)
9.3.2 Latin America Retinal Biologics Market Size by Application (2022-2027)
9.3.3 Latin America Retinal Biologics Market Size by Application (2016-2027)
9.4 Latin America Retinal Biologics Market Size by Country
9.4.1 Latin America Retinal Biologics Market Size by Country (2016-2021)
9.4.2 Latin America Retinal Biologics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Retinal Biologics Market Size (2016-2027)
10.2 Middle East & Africa Retinal Biologics Market Size by Type
10.2.1 Middle East & Africa Retinal Biologics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retinal Biologics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retinal Biologics Market Size by Type (2016-2027)
10.3 Middle East & Africa Retinal Biologics Market Size by Application
10.3.1 Middle East & Africa Retinal Biologics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retinal Biologics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retinal Biologics Market Size by Application (2016-2027)
10.4 Middle East & Africa Retinal Biologics Market Size by Country
10.4.1 Middle East & Africa Retinal Biologics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retinal Biologics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Spark Therapeutics, Inc
11.1.1 Spark Therapeutics, Inc Company Details
11.1.2 Spark Therapeutics, Inc Business Overview
11.1.3 Spark Therapeutics, Inc Retinal Biologics Introduction
11.1.4 Spark Therapeutics, Inc Revenue in Retinal Biologics Business (2016-2021)
11.1.5 Spark Therapeutics, Inc Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in Retinal Biologics Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Regeneron Pharmaceuticals, Inc
11.3.1 Regeneron Pharmaceuticals, Inc Company Details
11.3.2 Regeneron Pharmaceuticals, Inc Business Overview
11.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Introduction
11.3.4 Regeneron Pharmaceuticals, Inc Revenue in Retinal Biologics Business (2016-2021)
11.3.5 Regeneron Pharmaceuticals, Inc Recent Development
11.4 AbbVie Inc
11.4.1 AbbVie Inc Company Details
11.4.2 AbbVie Inc Business Overview
11.4.3 AbbVie Inc Retinal Biologics Introduction
11.4.4 AbbVie Inc Revenue in Retinal Biologics Business (2016-2021)
11.4.5 AbbVie Inc Recent Development
11.5 Johnson & Johnson Services, Inc
11.5.1 Johnson & Johnson Services, Inc Company Details
11.5.2 Johnson & Johnson Services, Inc Business Overview
11.5.3 Johnson & Johnson Services, Inc Retinal Biologics Introduction
11.5.4 Johnson & Johnson Services, Inc Revenue in Retinal Biologics Business (2016-2021)
11.5.5 Johnson & Johnson Services, Inc Recent Development
11.6 Amgen Inc
11.6.1 Amgen Inc Company Details
11.6.2 Amgen Inc Business Overview
11.6.3 Amgen Inc Retinal Biologics Introduction
11.6.4 Amgen Inc Revenue in Retinal Biologics Business (2016-2021)
11.6.5 Amgen Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Retinal Biologics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Macular Degeneration
Table 3. Key Players of Diabetic Retinopathy
Table 4. Key Players of Diabetic Macular Edema
Table 5. Key Players of Uveitis
Table 6. Key Players of Others
Table 7. Global Retinal Biologics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Retinal Biologics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Retinal Biologics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Retinal Biologics Market Share by Regions (2016-2021)
Table 11. Global Retinal Biologics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Retinal Biologics Market Share by Regions (2022-2027)
Table 13. Retinal Biologics Market Trends
Table 14. Retinal Biologics Market Drivers
Table 15. Retinal Biologics Market Challenges
Table 16. Retinal Biologics Market Restraints
Table 17. Global Retinal Biologics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Retinal Biologics Market Share by Players (2016-2021)
Table 19. Global Top Retinal Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Biologics as of 2020)
Table 20. Ranking of Global Top Retinal Biologics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Retinal Biologics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Retinal Biologics Product Solution and Service
Table 24. Date of Enter into Retinal Biologics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Retinal Biologics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Retinal Biologics Revenue Market Share by Type (2016-2021)
Table 28. Global Retinal Biologics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Retinal Biologics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Retinal Biologics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Retinal Biologics Revenue Market Share by Application (2016-2021)
Table 32. Global Retinal Biologics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Retinal Biologics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Retinal Biologics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Retinal Biologics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Retinal Biologics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Retinal Biologics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Retinal Biologics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Retinal Biologics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Retinal Biologics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Retinal Biologics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Retinal Biologics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Retinal Biologics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Retinal Biologics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Retinal Biologics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Retinal Biologics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Retinal Biologics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Retinal Biologics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Retinal Biologics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Retinal Biologics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Retinal Biologics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Retinal Biologics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Retinal Biologics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Retinal Biologics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Retinal Biologics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Retinal Biologics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Retinal Biologics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Retinal Biologics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Retinal Biologics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Retinal Biologics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Retinal Biologics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Retinal Biologics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Retinal Biologics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Spark Therapeutics, Inc Company Details
Table 65. Spark Therapeutics, Inc Business Overview
Table 66. Spark Therapeutics, Inc Retinal Biologics Product
Table 67. Spark Therapeutics, Inc Revenue in Retinal Biologics Business (2016-2021) & (US$ Million)
Table 68. Spark Therapeutics, Inc Recent Development
Table 69. F. Hoffmann-La Roche Ltd Company Details
Table 70. F. Hoffmann-La Roche Ltd Business Overview
Table 71. F. Hoffmann-La Roche Ltd Retinal Biologics Product
Table 72. F. Hoffmann-La Roche Ltd Revenue in Retinal Biologics Business (2016-2021) & (US$ Million)
Table 73. F. Hoffmann-La Roche Ltd Recent Development
Table 74. Regeneron Pharmaceuticals, Inc Company Details
Table 75. Regeneron Pharmaceuticals, Inc Business Overview
Table 76. Regeneron Pharmaceuticals, Inc Retinal Biologics Product
Table 77. Regeneron Pharmaceuticals, Inc Revenue in Retinal Biologics Business (2016-2021) & (US$ Million)
Table 78. Regeneron Pharmaceuticals, Inc Recent Development
Table 79. AbbVie Inc Company Details
Table 80. AbbVie Inc Business Overview
Table 81. AbbVie Inc Retinal Biologics Product
Table 82. AbbVie Inc Revenue in Retinal Biologics Business (2016-2021) & (US$ Million)
Table 83. AbbVie Inc Recent Development
Table 84. Johnson & Johnson Services, Inc Company Details
Table 85. Johnson & Johnson Services, Inc Business Overview
Table 86. Johnson & Johnson Services, Inc Retinal Biologics Product
Table 87. Johnson & Johnson Services, Inc Revenue in Retinal Biologics Business (2016-2021) & (US$ Million)
Table 88. Johnson & Johnson Services, Inc Recent Development
Table 89. Amgen Inc Company Details
Table 90. Amgen Inc Business Overview
Table 91. Amgen Inc Retinal Biologics Product
Table 92. Amgen Inc Revenue in Retinal Biologics Business (2016-2021) & (US$ Million)
Table 93. Amgen Inc Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Biologics Market Share by Type: 2020 VS 2027
Figure 2. Macular Degeneration Features
Figure 3. Diabetic Retinopathy Features
Figure 4. Diabetic Macular Edema Features
Figure 5. Uveitis Features
Figure 6. Others Features
Figure 7. Global Retinal Biologics Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Retinal Biologics Report Years Considered
Figure 12. Global Retinal Biologics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Retinal Biologics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Retinal Biologics Market Share by Regions: 2020 VS 2027
Figure 15. Global Retinal Biologics Market Share by Regions (2022-2027)
Figure 16. Global Retinal Biologics Market Share by Players in 2020
Figure 17. Global Top Retinal Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Biologics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Retinal Biologics Revenue in 2020
Figure 19. Global Retinal Biologics Revenue Market Share by Type (2016-2021)
Figure 20. Global Retinal Biologics Revenue Market Share by Type (2022-2027)
Figure 21. North America Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Retinal Biologics Market Share by Type (2016-2027)
Figure 23. North America Retinal Biologics Market Share by Application (2016-2027)
Figure 24. North America Retinal Biologics Market Share by Country (2016-2027)
Figure 25. United States Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Retinal Biologics Market Share by Type (2016-2027)
Figure 29. Europe Retinal Biologics Market Share by Application (2016-2027)
Figure 30. Europe Retinal Biologics Market Share by Country (2016-2027)
Figure 31. Germany Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Retinal Biologics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Retinal Biologics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Retinal Biologics Market Share by Region (2016-2027)
Figure 41. China Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Retinal Biologics Market Share by Type (2016-2027)
Figure 49. Latin America Retinal Biologics Market Share by Application (2016-2027)
Figure 50. Latin America Retinal Biologics Market Share by Country (2016-2027)
Figure 51. Mexico Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Retinal Biologics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Retinal Biologics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Retinal Biologics Market Share by Country (2016-2027)
Figure 57. Turkey Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Spark Therapeutics, Inc Revenue Growth Rate in Retinal Biologics Business (2016-2021)
Figure 61. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Retinal Biologics Business (2016-2021)
Figure 62. Regeneron Pharmaceuticals, Inc Revenue Growth Rate in Retinal Biologics Business (2016-2021)
Figure 63. AbbVie Inc Revenue Growth Rate in Retinal Biologics Business (2016-2021)
Figure 64. Johnson & Johnson Services, Inc Revenue Growth Rate in Retinal Biologics Business (2016-2021)
Figure 65. Amgen Inc Revenue Growth Rate in Retinal Biologics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---